Retraction Note to: Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer Haifeng ZongYang ZhangYehuang Wang Retraction Note 22 September 2015 Article: 243
Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial Sebastian OchenduszkoMiroslawa PuskulluogluKrzysztof Krzemieniecki Original Paper Open access 09 September 2015 Article: 242
A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer Ming CuiZiyu LiXiangqian Su Original Paper 08 September 2015 Article: 241
Efficacy and safety of pirarubicin plus capecitabine versus pirarubicin plus cyclophosphamide in Chinese node-negative breast cancer patients: a 4-year open-label, randomized, controlled study Xiaohui ZhangYidong ZhouQiang Sun Original Paper 07 September 2015 Article: 240
TRAF6 is required for BLyS-mediated NF-κB signaling in multiple myeloma cells Xinfeng WangJingjing WangHongming Huang Original Paper 03 September 2015 Article: 239
Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma Jianhua LiXinguang QiuShuijun Zhang Original Paper 02 September 2015 Article: 238
Is the exhaled breath temperature in lung cancer influenced by airways neoangiogenesis or by inflammation? Giovanna E. CarpagnanoDonato LacedoniaMaria P. Foschino-Barbaro Original Paper 01 September 2015 Article: 237
Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia Gilles FreyerEwa Kalinka-WarzochaZsolt Szabo Original Paper 28 August 2015 Article: 236
Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer Yasuyoshi MiyataAkihiro AsaiHideki Sakai Original Paper Open access 27 August 2015 Article: 235
